O

Optomed Oyj
OMXH:OPTOMED

Watchlist Manager
Optomed Oyj
OMXH:OPTOMED
Watchlist
Price: 3.87 EUR 1.71% Market Closed
Market Cap: 76.2m EUR

Wall Street
Price Targets

OPTOMED Price Targets Summary
Optomed Oyj

Wall Street analysts forecast OPTOMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPTOMED is 5.2 EUR with a low forecast of 4.04 EUR and a high forecast of 5.78 EUR.

Lowest
Price Target
4.04 EUR
4% Upside
Average
Price Target
5.2 EUR
34% Upside
Highest
Price Target
5.78 EUR
49% Upside
Optomed Oyj Competitors:
Price Targets
7733
Olympus Corp
47% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
6% Upside
7575
Japan Lifeline Co Ltd
11% Upside
605186
Shanghai General Healthy Information and Technology Co Ltd
22% Upside
HYPR
Hyperfine Inc
74% Upside
OBI
Ondine Biomedical Inc
447% Upside
688677
Qingdao NovelBeam Technology Co Ltd
64% Upside
MDT
Medtronic PLC
10% Upside

Revenue
Forecast

Revenue Estimate
Optomed Oyj

For the last 5 years the compound annual growth rate for Optomed Oyj's revenue is 0%. The projected CAGR for the next 3 years is 37%.

0%
Past Growth
37%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Optomed Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat

Net Income
Forecast

Net Income Estimate
Optomed Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPTOMED's stock price target?
Price Target
5.2 EUR

According to Wall Street analysts, the average 1-year price target for OPTOMED is 5.2 EUR with a low forecast of 4.04 EUR and a high forecast of 5.78 EUR.

What is Optomed Oyj's Revenue forecast?
Projected CAGR
37%

For the last 5 years the compound annual growth rate for Optomed Oyj's revenue is 0%. The projected CAGR for the next 3 years is 37%.

Back to Top